logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Berkes, Ivan
    Born in June 1968
    Individual (16 offsprings)
    Officer
    2015-03-10 ~ now
    OF - Director → CIF 0
    Mr Ivan Berkes
    Born in June 1968
    Individual (16 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
Ceased 2
  • 1
    Farrington, Jonathan George
    Director born in March 1969
    Individual (1 offspring)
    Officer
    2016-01-07 ~ 2023-06-16
    OF - Director → CIF 0
  • 2
    Dorris, Simon James, Dr
    Director born in July 1971
    Individual (7 offsprings)
    Officer
    2016-01-07 ~ 2025-08-15
    OF - Director → CIF 0
parent relation
Company in focus

LONDON PHARMA CAPITAL LIMITED

Previous name
WAGOSI LIMITED - 2015-11-04
Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Fixed Assets - Investments
4,627 GBP2023-12-31
4,627 GBP2022-12-31
Debtors
440,417 GBP2023-12-31
440,417 GBP2022-12-31
Cash at bank and in hand
1,285,226 GBP2023-12-31
1,285,226 GBP2022-12-31
Current Assets
1,725,643 GBP2023-12-31
1,725,643 GBP2022-12-31
Net Current Assets/Liabilities
1,230,782 GBP2023-12-31
1,230,782 GBP2022-12-31
Total Assets Less Current Liabilities
1,235,409 GBP2023-12-31
1,235,409 GBP2022-12-31
Equity
Called up share capital
100 GBP2023-12-31
100 GBP2022-12-31
Share premium
88,277 GBP2023-12-31
88,277 GBP2022-12-31
Retained earnings (accumulated losses)
1,147,032 GBP2023-12-31
1,147,032 GBP2022-12-31
Equity
1,235,409 GBP2023-12-31
1,235,409 GBP2022-12-31
Average Number of Employees
42023-01-01 ~ 2023-12-31
42022-01-01 ~ 2022-12-31
Investments in group undertakings and participating interests
4,627 GBP2023-12-31
4,627 GBP2022-12-31

Related profiles found in government register
  • LONDON PHARMA CAPITAL LIMITED
    Info
    WAGOSI LIMITED - 2015-11-04
    Registered number 09482452
    Fifth Floor Watson House, 54-60 Baker Street, London W1U 7BU
    PRIVATE LIMITED COMPANY incorporated on 2015-03-10 (10 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-07
    CIF 0
  • LONDON PHARMA CAPITAL LIMITED
    S
    Registered number 09482452
    Fifth Floor, Watson House, 54-60 Baker Street, London, United Kingdom, W1U 7BU
    Private Limited Company in Registrar Of Companies In England & Wales, England
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • MEDPRO HEALTH LIMITED - 2024-04-06
    PRAGEN PHARMA LIMITED - 2019-02-26
    UNION PHARMA LIMITED - 2015-10-19
    Fifth Floor Watson House, 54-60 Baker Street, London, United Kingdom
    Active Corporate (2 parents)
    Equity (Company account)
    -770 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.